New hope for lung cancer: Pre-Surgery drug trial launches

NCT ID NCT05714891

Ongoing Disease control Sponsor: Canadian Cancer Trials Group Source: ClinicalTrials.gov ↗

First seen Nov 20, 2025 · Last updated May 15, 2026 · Updated 17 times

Summary

This study tests new treatments for non-small cell lung cancer given before surgery. The goal is to see if these treatments shrink tumors and make surgery more effective. About 4 adults with early-stage lung cancer that can be removed surgically are taking part. The main focus is on how well the tumor responds to the treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NSCLC are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

CHUM-Centre Hospitalier de l'Universite de Montreal

Montreal, Quebec, H2X 3E4, Canada
CancerCare Manitoba

Winnipeg, Manitoba, R3E 0V9, Canada
Kingston Health Sciences Centre

Kingston, Ontario, K7L 2V7, Canada
London Health Sciences Centre Research Inc.

London, Ontario, N6A 5W9, Canada
Ottawa Hospital Research Institute

Ottawa, Ontario, K1H 8L6, Canada
The Research Institute of the McGill University

Montreal, Quebec, H4A 3J1, Canada
University Health Network

Toronto, Ontario, M5G 2M9, Canada
University Institute of Cardiology and

Québec, Quebec, G1V 4G5, Canada

Conditions

Explore the condition pages connected to this study.

NSCLC